A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors
- Park, John (Primary Chief Investigator)
- Sabanathan, Dhanusha (Associate Investigator)
- Gurney, Howard (Associate Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Rai, Meenal (Clinical Trial Unit Staff)
Project: Research